Asia-Pacific Fluorescent Immunoassay Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis – by Product Type (ELISA, Rapid Lateral Flow Immunoassay, and Others), Application (Infectious Diseases, Oncology, Cardiovascular Diseases, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others) 

No. of Pages: 167
Report Code: BMIRE00025659
Category: Life Sciences
Asia-Pacific Fluorescent Immunoassay Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia-Pacific Fluorescent Immunoassay Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia-Pacific Fluorescent Immunoassay Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia-Pacific Fluorescent Immunoassay Market Regional Analysis

6.2 Asia-Pacific Fluorescent Immunoassay Market Revenue 2019-2028 (US$ Million)
6.3 Asia-Pacific Fluorescent Immunoassay Market Forecast Analysis

7. Asia-Pacific Fluorescent Immunoassay Market Analysis – by Product Type

7.1 ELISA
  • 7.1.1 Overview
  • 7.1.2 ELISA: Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Rapid Lateral Flow Immunoassay
  • 7.2.1 Overview
  • 7.2.2 Rapid Lateral Flow Immunoassay: Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Asia-Pacific Fluorescent Immunoassay Market Analysis – by Application

8.1 Infectious Diseases
  • 8.1.1 Overview
  • 8.1.2 Infectious Diseases: Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Oncology
  • 8.2.1 Overview
  • 8.2.2 Oncology: Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Cardiovascular Diseases
  • 8.3.1 Overview
  • 8.3.2 Cardiovascular Diseases: Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Asia-Pacific Fluorescent Immunoassay Market Analysis – by End User

9.1 Hospitals & Clinics
  • 9.1.1 Overview
  • 9.1.2 Hospitals & Clinics: Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Diagnostic Centers
  • 9.2.1 Overview
  • 9.2.2 Diagnostic Centers: Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Pharmaceutical & Biotechnology Companies
  • 9.3.1 Overview
  • 9.3.2 Pharmaceutical & Biotechnology Companies: Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Academic & Research Institutes
  • 9.4.1 Overview
  • 9.4.2 Academic & Research Institutes: Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Asia-Pacific Fluorescent Immunoassay Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific
  • 10.2.1 Asia-Pacific Fluorescent Immunoassay Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.2.1.1 Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 China: Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 China: Asia-Pacific Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.1.2 China: Asia-Pacific Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.1.3 China: Asia-Pacific Fluorescent Immunoassay Market Breakdown, by End User
  • 10.2.1.2 India: Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 India: Asia-Pacific Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.2.2 India: Asia-Pacific Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.2.3 India: Asia-Pacific Fluorescent Immunoassay Market Breakdown, by End User
  • 10.2.1.3 Japan: Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 Japan: Asia-Pacific Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.3.2 Japan: Asia-Pacific Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.3.3 Japan: Asia-Pacific Fluorescent Immunoassay Market Breakdown, by End User
  • 10.2.1.4 Australia: Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Australia: Asia-Pacific Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.4.2 Australia: Asia-Pacific Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.4.3 Australia: Asia-Pacific Fluorescent Immunoassay Market Breakdown, by End User
  • 10.2.1.5 Rest of Asia-Pacific : Asia-Pacific Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.5.1 Rest of Asia-Pacific : Asia-Pacific Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.2.1.5.2 Rest of Asia-Pacific : Asia-Pacific Fluorescent Immunoassay Market Breakdown, by Application
    • 10.2.1.5.3 Rest of Asia-Pacific : Asia-Pacific Fluorescent Immunoassay Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 BD
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 bioMerieux SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Danaher
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Ortho Clinical Diagnostics Holdings plc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Quidel Corporation
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Siemens AG
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Sysmex Corporation
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Asia-Pacific Fluorescent Immunoassay Market

  • Abbott
  • BD
  • bioMerieux SA
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Ortho Clinical Diagnostics Holdings plc
  • Quidel Corporation
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)